Copy to clipboard 
DuPont entered into a definitive agreement to acquire Spectrum Plastics Group from AEA Investors. The transaction is expected to close by the end of 3Q23.
Update August 1, 2023: This transaction is complete.
Spectrum provides advanced injection molding solutions to the world’s orthopedic and sports medicine companies, and is a leader in the advanced manufacturing of specialty medical devices and components, serving 22 of the top 26 medical device OEMs with a strategic focus on key fast-growing therapeutic areas such as structural heart, electrophysiology, surgical robotics and cardiovascular.
Spectrum is fully aligned with DuPont’s strategic objective of delivering innovative specialized materials and solutions into attractive end markets with long-term secular growth trends.
“We have been focused on Spectrum for a long time and our team is extremely excited for this opportunity,” said Ed Breen, Executive Chairman and Chief Executive Officer of DuPont. “Spectrum is a compelling strategic complement to our existing healthcare portfolio, which already includes businesses with best-in-class innovation, deep customer relationships and with strong growth and profitability. With this combination, we’ll be able to offer customers additional innovation and manufacturing capabilities with a broader and more integrated solution set.”
Source: DuPont
